Diagonal Therapeutics

Bishop chess chess bishop diagonal chessboard

Series B round of $125M will fund Diagonal's move into clinic

With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug, DIAG723.

Kevin Dunleavy Jan 8, 2026 6:30am

Pfizer’s reputation wrangler plans departure—Chutes & Ladders

Jul 11, 2025 8:30am

Graphic images of red and white pill capsules lined up diagonally in front of a yellow background

Diagonal launches with $128M to grow agonist antibody platform

Apr 3, 2024 6:00am